Shandong Weigao Group Medical Polymer Company Limited Informations sur les dividendes
Shandong Weigao Group Medical Polymer Company Limited a un dividende annuel de 0.03 par action, avec un rendement de 0.00%. Le dividende est payé semestriellement et la dernière date d'ex-dividende était le Oct 21, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$0.03
Oct 21, 2025
Fréquence des paiements
Taux de distribution
Semestriellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Oct 21, 2025
$0.1061
Oct 22, 2025
Nov 21, 2025
Oct 20, 2025
$0.0969
Oct 21, 2025
Nov 21, 2025
Jun 2, 2025
$0.1344
Jun 3, 2025
Jul 11, 2025
Oct 18, 2024
$0.1009
Oct 21, 2024
Nov 22, 2024
Jun 3, 2024
$0.1035
Jun 4, 2024
Jul 12, 2024
Oct 19, 2023
$0.08
Oct 20, 2023
Nov 24, 2023
Graphiques des dividendes
SHWGF Dividendes
SHWGF Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par Shandong Weigao Group Medical Polymer Company Limited et son dividende annuel ?
Quel est le ratio de distribution de dividendes de Shandong Weigao Group Medical Polymer Company Limited ?
Quelle est la date ex-dividende pour SHWGF ?
À quelle fréquence Shandong Weigao Group Medical Polymer Company Limited verse-t-elle des dividendes ?
Statistiques clés
Clôture préc.
$0.69
Prix d'ouverture
$0.6899
Plage de la journée
$0.6899 - $0.69
Plage de 52 semaines
$0.66 - $0.76
Volume
468
Volume moyen
0
BPA (TTM)
0.06
Rendement en dividend
--
Capitalisation boursière
$3.0B
Qu’est-ce que SHANDONG WEIGAO GROUP MEDICAL ?
Shandong Weigao Group Medical Polymer Co. Ltd. engages in the research and development, production, and sale of single-use medical device products and operates finance lease and factoring. The company is headquartered in Weihai, Shandong and currently employs 13,063 full-time employees. The company went IPO on 2004-02-27. The firm operates its businesses through six segments. The Medical Device segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The firm mainly operates its businesses in the domestic and overseas markets.